Increased life expectancy is posing unprecedented challenges to healthcare systems
worldwide. These include a sharp increase in the prevalence of chronic kidney disease …

The number of patients with end-stage kidney disease 65 years and older is growing, and
this growth is expected to continue. The presence of medical comorbidities, limited life …

Background Annual decline in kidney function is a widely applied surrogate outcome of
renal failure. It is important to understand the relationships between known risk factors and …

COVID-19 is strongly influenced by age and comorbidities. Acute kidney injury (AKI) is a
frequent finding in COVID-19 patients and seems to be associated to mortality and severity …

Background Although a reduced glomerular filtration rate (GFR) in old people has been
attributed to physiologic aging, it may be associated with kidney disease or superimposed …

Background Longer life expectancy is associated with an increasing prevalence of kidney
disease. Aging itself may cause renal damage, but the spectrum of kidney disorders that …

The world population is aging, and the prevalence of chronic kidney disease (CKD) is
increasing. Whether this increase is also due to the methods currently being used to assess …

Backgrounds. Chronic kidney disease (CKD), anemia, and mobility limitation are important
predictors of mortality. We aimed at investigating the interactions between estimated …

Background Decline of renal function is common in older persons and the prevalence of
chronic kidney disease (CKD) is rising with ageing. CKD affects different outcomes relevant …

Objective: To summarize current evidence about mechanisms, clinical features, diagnostic
issues, and strategies for prevention of medication-induced nephrotoxicity among older …